PubMed

An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.

Cardillo JA, Farah ME, Mitre J, Morales PH, Costa RA, Melo LA, Kuppermann B, Jorge R, Ashton P.

Br J Ophthalmol. 2004 Sep;88(9):1201-5.PMID: 15317716 [PubMed - indexed for MEDLINE]Related articlesFree article

An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy.

Yang CS, Khawly JA, Hainsworth DP, Chen SN, Ashton P, Guo H, Jaffe GJ.

Arch Ophthalmol. 1998 Jan;116(1):69-77.PMID: 9445210 [PubMed - indexed for MEDLINE]Related articles

Intravitreal sustained release corticosteroid-5-fluoruracil conjugate in the treatment of experimental proliferative vitreoretinopathy.

Berger AS, Cheng CK, Pearson PA, Ashton P, Crooks PA, Cynkowski T, Cynkowska G, Jaffe GJ.

Invest Ophthalmol Vis Sci. 1996 Oct;37(11):2318-25.PMID: 8843916 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil.

Rubsamen PE, Davis PA, Hernandez E, O'Grady GE, Cousins SW.

Arch Ophthalmol. 1994 Mar;112(3):407-13.PMID: 8129669 [PubMed - indexed for MEDLINE]Related articles

Effects of an intravitreal daunomycin implant on experimental proliferative vitreoretinopathy: simultaneous pharmacokinetic and pharmacodynamic evaluations.

Rahimy MH, Peyman GA, Fernandes ML, el-Sayed SH, Luo Q, Borhani H.

J Ocul Pharmacol. 1994 Fall;10(3):561-70.PMID: 7836865 [PubMed - indexed for MEDLINE]Related articles

Use of perfluorocarbon liquids, silicone oil, and 5-fluorouracil in the management of experimental PVR.

Hegazy HM, Peyman GA, Liang C, Unal MH, Molinari LC, Kazi AA.

Int Ophthalmol. 1998-1999;22(4):239-46.PMID: 10674869 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of the fluocinolone/5-fluorouracil codrug in the gas-filled eye.

Perkins SL, Gallemore RP, Yang CH, Guo H, Ashton P, Jaffe GJ.

Retina. 2000;20(5):514-9.PMID: 11039427 [PubMed - indexed for MEDLINE]Related articles

Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FU.

Borhani H, Peyman GA, Rahimy MH, Thompson H.

Int Ophthalmol. 1995;19(1):43-9.PMID: 8537196 [PubMed - indexed for MEDLINE]Related articles

Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy.

Hashizoe M, Ogura Y, Takanashi T, Kunou N, Honda Y, Ikada Y.

Curr Eye Res. 1995 Jun;14(6):473-7.PMID: 7671629 [PubMed - indexed for MEDLINE]Related articles

Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ogura Y.

Graefes Arch Clin Exp Ophthalmol. 2002 Aug;240(8):672-8. Epub 2002 Jul 12.PMID: 12192462 [PubMed - indexed for MEDLINE]Related articles

Liposome-encapsulated 5-fluorouracil in the treatment of proliferative vitreoretinopathy.

Joondeph BC, Peyman GA, Khoobehi B, Yue BY.

Ophthalmic Surg. 1988 Apr;19(4):252-6.PMID: 3362494 [PubMed - indexed for MEDLINE]Related articles

[Effects of hypericin on traumatic proliferative vitreoretinopathy in rabbits]

Gao Q, Hui Y, Wang Y.

Yan Ke Xue Bao. 2002 Dec;18(4):240-5. Chinese. PMID: 15515769 [PubMed - indexed for MEDLINE]Related articles

The antidepressant hypericin inhibits progression of experimental proliferative vitreoretinopathy.

Tahara YR, Sakamoto TR, Oshima YR, Ishibashi TR, Inomata HR, Murata TR, Hinton DR, Ryan SJ.

Curr Eye Res. 1999 Oct;19(4):323-9.PMID: 10520228 [PubMed - indexed for MEDLINE]Related articles

Combined 5-fluorouracil, low-molecular-weight heparin, and silicone oil in the management of complicated retinal detachment with proliferative vitreoretinopathy grade C.

Garcia RA, Sanchez JG, Arevalo JF.

Ophthalmic Surg Lasers Imaging. 2007 Jul-Aug;38(4):276-82.PMID: 17674917 [PubMed - indexed for MEDLINE]Related articles

Transferrin-ricin A chain toxin limits the development of experimental proliferative vitreoretinopathy.

Handa JT, Keithahn MA, Jaffe GJ.

Exp Eye Res. 1996 Jun;62(6):689-96.PMID: 8983950 [PubMed - indexed for MEDLINE]Related articles

Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR.

Giordano GG, Refojo MF, Arroyo MH.

Invest Ophthalmol Vis Sci. 1993 Aug;34(9):2743-51.PMID: 8344796 [PubMed - indexed for MEDLINE]Related articlesFree article

Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin.

Kumar A, Tewari HK, Bathwal DP, Khosla PK.

Indian J Ophthalmol. 1994 Mar;42(1):31-5.PMID: 7927629 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit.

Wong CG, Rich KA, Liaw LH, Hsu HT, Berns MW.

Curr Eye Res. 2001 Feb;22(2):140-7.PMID: 11402391 [PubMed - indexed for MEDLINE]Related articles

Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy.

Mandava N, Blackburn P, Paul DB, Wilson MW, Read SB, Alspaugh E, Tritz R, Barber JR, Robbins JM, Kruse CA.

Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3338-48.PMID: 12356843 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.

Jaffe GJ, Yang CS, Wang XC, Cousins SW, Gallemore RP, Ashton P.

Ophthalmology. 1998 Jan;105(1):46-56.PMID: 9442778 [PubMed - indexed for MEDLINE]Related articles